Dabigatran - Globe Thesis

Keyword [Dabigatran] Result: 41 - 60 \| Page: 3 of 4
41.	The Efficacy And Safety Of Dabigatrol In Elderly Patients With Non-valvular Atrial Fibrillation Complicated By Renal Insufficiency
42.	Study On TDM Monitoring,Hemorrhage Risk And Thrombosis Risk Of Dabigatran Etexilate In NVAF Patients For Atrial Fibrillation Ablation In China
43.	An Observational Study Of Novel Oral Anticoagulants In Elderly Patients With Nonvalvular Atrial Fibrillation
44.	Study On The Effect Of New Oral Anticoagulant On Platelet Function And Coagulation Function In Patients With Atrial Fibrillation
45.	Safety And Efficacy Of NOACs In Patients With Non-valvular Atrial Fibrillation
46.	Direct Comparative Efficacy And Safety Of Novel Oral Anticoagulants In Patients With Atrial Fibrillation:A Systematic Review And Meta-analysis
47.	Efficacy And Safety Of Dabigatran And Rivaroxaban In The Treatment Of Patients With Nonvalvular Atrial Fibrillation
48.	Association Between Platelet Count And The Risk Of Bleeding Among Patients With Nonvalvular Atrial Fibrillation Taking Dabigatran After Radiofrequency Ablation
49.	Observation On The Efficacy Of New Anticoagulants In The Treatment Of Cerebral Venous And Sinus Thrombosis
50.	Dabigatran Ameliorates Human Airway Smooth Muscle Cells Remodeling By Modulating YAP
51.	Clinical Study Of Dabigatran Etexilate On Rehabilitation In Patients With Atrial Fibrillation Combined With Cerebral Embolism By DTI And NSE
52.	Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for the prevention of stroke prophylaxis in atrial fibrillation
53.	Dabigatran versus warfarin for the prevention of stroke in patients with chronic nonvalvular atrial fibrillation
54.	The influence of socioeconomic status on selection of anticoagulation for atrial fibrillation: A population based study
55.	The Effect And Mechanism Of Dabigatran On The Coagulation Status
56.	A Prospective Study On Postoperative Prevention Of Deep Venous Thrombosis In Patients With Varicose Veins In The Lower Extremities At Moderate Risk Thrombosis
57.	Comparison Of The Application Of Antithrombotic Therapy Dabigatran Etexilate And Rivaroxaban In High Bleeding Risk Patients With ACS And NVAF Undering PCI
58.	Effecacy And Safety Of Dabigatran In Ederly With Nonvalvular Atrial Brillation:A Meta Analysis
59.	Health Technology Evaluation Of Four New Oral Anticoagulants
60.	Pharmacokinetics Of Ezetimibe Tablets And Dabigatran Etexilate Capsules
<<First <Prev Next> Last>> Jump to